Laura Heydmann-Meiss
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.
Journal: Science translational medicine
Published: June 03, 2026
Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix.
Journal: Scientific reports
Published: December 02, 2024
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease.
Journal: eGastroenterology
Published: October 30, 2024
CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1.
Journal: JHEP reports : innovation in hepatology
Published: November 10, 2023
Targeting the liver clock improves fibrosis by restoring TGF-β signaling.
Journal: Journal of hepatology
Published: May 05, 2023
JAK1 promotes HDV replication and is a potential target for antiviral therapy.
Journal: Journal of hepatology
Published: March 30, 2023
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.
Journal: The Journal of clinical investigation
Published: February 02, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026